These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2675118)

  • 21. Report of a case of P. falciparum malaria resistant to chloroquine and combination of sulfalene and pyrimethamine in Delhi.
    Choudhury DS; Sinha S; Ghosh SK; Devi CU; Sharma VP
    Indian J Malariol; 1987 Jun; 24(1):95-6. PubMed ID: 3326756
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of the Plasmodium falciparum response to chloroquine, quinine and mefloquine].
    Di Santi SM; Camargo Neves VL; Boulos M; Dutra AP; Ramos AM; Santos M; Barata LC
    Rev Inst Med Trop Sao Paulo; 1988; 30(3):147-52. PubMed ID: 3065907
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug resistance in malaria: three cases and a review.
    Isaac-Renton JL; Koon AL; Chan RM; Chow AW; Sacks SL
    Can Med Assoc J; 1983 Sep; 129(5):454-7. PubMed ID: 6349767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The pharmacology of antimalarials].
    Fernex M; Leimer R
    Schweiz Rundsch Med Prax; 1986 Apr; 75(16):438-45. PubMed ID: 3518010
    [No Abstract]   [Full Text] [Related]  

  • 25. Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006.
    Parola P; Pradines B; Simon F; Carlotti MP; Minodier P; Ranjeva MP; Badiaga S; Bertaux L; Delmont J; Morillon M; Silai R; Brouqui P; Parzy D
    Am J Trop Med Hyg; 2007 Sep; 77(3):431-7. PubMed ID: 17827355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amodiaquine: the exempted antimalarial drug in Ethiopia.
    Mengesha T; Seboxa T
    Ethiop Med J; 1998 Oct; 36(4):277-8. PubMed ID: 11957304
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of mefloquine as an antimalarial].
    Bull World Health Organ; 1983; 61(3):401-11. PubMed ID: 6411373
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
    Price RN; Nosten F
    Drug Resist Updat; 2001 Jun; 4(3):187-96. PubMed ID: 11768332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of Plasmodium falciparum resistance to antimalarial drugs].
    Parzy D; Pradines B; Keundjian A; Fusai T; Doury JC
    Med Trop (Mars); 1995; 55(3):211-5. PubMed ID: 8559012
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent developments in naturally derived antimalarials: cryptolepine analogues.
    Wright CW
    J Pharm Pharmacol; 2007 Jun; 59(6):899-904. PubMed ID: 17637183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium/calmodulin functions in P. falciparum in vitro--implications for antiprotozoal drug design.
    Scheibel LW; Colombani PM; Hess AD; Aikawa M; Atkinson CT; Igarashi I; Matsumoto Y; Milhous WK
    Prog Clin Parasitol; 1989; 1():21-56. PubMed ID: 2491694
    [No Abstract]   [Full Text] [Related]  

  • 32. Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug design.
    Scheibel LW; Colombani PM; Hess AD; Aikawa M; Atkinson CT; Milhous WK
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7310-4. PubMed ID: 3313391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction. Antimalarial drug resistance: ramifications, explanations and challenges.
    Ridley RG
    Microbes Infect; 2002 Feb; 4(2):155-6. PubMed ID: 11880046
    [No Abstract]   [Full Text] [Related]  

  • 34. Borrelidin, a potent antimalarial: stage-specific inhibition profile of synchronized cultures of Plasmodium falciparum.
    Ishiyama A; Iwatsuki M; Namatame M; Nishihara-Tsukashima A; Sunazuka T; Takahashi Y; Ōmura S; Otoguro K
    J Antibiot (Tokyo); 2011 May; 64(5):381-4. PubMed ID: 21343942
    [No Abstract]   [Full Text] [Related]  

  • 35. An in vitro microtechnique for testing antimalarials--use of cultured Plasmodium falciparum parasites.
    Gajanana A; Sivaraman CA; Sinha S; Sivaraman A; Rai Chowdhuri AN
    Indian J Med Res; 1982 Jun; 75():802-7. PubMed ID: 6752012
    [No Abstract]   [Full Text] [Related]  

  • 36. Collaborative drug discovery and the Tres Cantos Antimalarial Set (TCAMS).
    Cabrera AC
    Drug Discov Today; 2019 Jun; 24(6):1304-1310. PubMed ID: 30980903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pernicious malaria seizure. Present status and new characteristics].
    Vachon F
    Rev Prat; 1989 Mar; 39(8):683-8. PubMed ID: 2657989
    [No Abstract]   [Full Text] [Related]  

  • 38. Global phenotypic screening for antimalarials.
    Guiguemde WA; Shelat AA; Garcia-Bustos JF; Diagana TT; Gamo FJ; Guy RK
    Chem Biol; 2012 Jan; 19(1):116-29. PubMed ID: 22284359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cycloprodigiosin hydrochloride obtained from Pseudoalteromonas denitrificans is a potent antimalarial agent.
    Kim HS; Hayashi M; Shibata Y; Wataya Y; Mitamura T; Horii T; Kawauchi K; Hirata H; Tsuboi S; Moriyama Y
    Biol Pharm Bull; 1999 May; 22(5):532-4. PubMed ID: 10375177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applying malaria parasite's heme detoxification system for screening potential antimalarial drugs.
    Sahal D; Kannan R; Chauhan VS
    Anal Biochem; 2003 Jan; 312(2):258-60. PubMed ID: 12531215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.